The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity

References

• Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486–11. doi:10.1038/nri3862.
   PubMed Web of Science ®Google Scholar
• Philip M, Schietinger A. CD8(+) T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209–223. doi:10.1038/s41577-021-00574-3.
   PubMed Web of Science ®Google Scholar
• Feucht J, Sun J, Eyquem J, Ho Y-J, Zhao Z, Leibold J, Dobrin A, Cabriolu A, Hamieh M, Sadelain M. et al. Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat Med. 2019;25(1):82–88. doi:10.1038/s41591-018-0290-5.
   PubMed Web of Science ®Google Scholar
• Gumber D, Wang LD. Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion. EBioMedicine. 2022;77:103941. doi:10.1016/j.ebiom.2022.103941.
   PubMed Web of Science ®Google Scholar
• Delgoffe GM, Xu C, Mackall CL, Green MR, Gottschalk S, Speiser DE, Zehn D, Beavis PA. The role of exhaustion in CAR T cell therapy. Cancer Cell. 2021;39(7):885–888. doi:10.1016/j.ccell.2021.06.012.
   PubMed Web of Science ®Google Scholar
• Chapman NM, Boothby MR, Chi H. Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2020;20(1):55–70. doi:10.1038/s41577-019-0203-y.
   PubMed Web of Science ®Google Scholar
• Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2(10):1001–1012. doi:10.1038/s42255-020-00280-9.
   PubMedGoogle Scholar
• Li X, Wenes M, Romero P, Huang SCC, Fendt S-M, Ho P-C. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol. 2019;16(7):425–441. doi:10.1038/s41571-019-0203-7.
   PubMed Web of Science ®Google Scholar
• DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21(12):785–797. doi:10.1038/s41577-021-00541-y.
   PubMed Web of Science ®Google Scholar
• Tan H, Yang K, Li Y, Shaw TI, Wang Y, Blanco DB, Wang X, Cho J-H, Wang H, Rankin S. et al. Integrative proteomics and phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation. Immunity. 2017;46(3):488–503. doi:10.1016/j.immuni.2017.02.010.
   PubMed Web of Science ®Google Scholar
• Bourens M, Barrientos A. A CMC1-knockout reveals translation-independent control of human mitochondrial complex IV biogenesis. EMBO Rep. 2017;18(3):477–494. doi:10.15252/embr.201643103.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun L, Chen Z, Liu W, Xu Q, Liu F, Ma M, Chen Y, Lu Y, Fang H. et al. The immune-metabolic crosstalk between CD3(+)C1q(+)TAM and CD8(+)T cells associated with relapse-free survival in HCC. Front Immunol. 2023;14:1033497. doi:10.3389/fimmu.2023.1033497.
   PubMed Web of Science ®Google Scholar
• Buck MD, O’Sullivan D, Klein Geltink R, Curtis J, Chang C-H, Sanin D, Qiu J, Kretz O, Braas D, van der Windt GW. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166(1):63–76. doi:10.1016/j.cell.2016.05.035.
   PubMed Web of Science ®Google Scholar
• Vardhana SA, Hwee MA, Berisa M, Wells DK, Yost KE, King B, Smith M, Herrera PS, Chang HY, Satpathy AT. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol. 2020;21(9):1022–1033. doi:10.1038/s41590-020-0725-2.
   PubMed Web of Science ®Google Scholar
• Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, Peralta R, Wang Y, Wang Y, DePeaux K. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021;22(2):205–215. doi:10.1038/s41590-020-00834-9.
   PubMed Web of Science ®Google Scholar
• Lisci M, Barton PR, Randzavola LO, Ma CY, Marchingo JM, Cantrell DA, Paupe V, Prudent J, Stinchcombe JC, Griffiths GM. et al. Mitochondrial translation is required for sustained killing by cytotoxic T cells. Science. 2021;374(6565):eabe9977. doi:10.1126/science.abe9977.
   PubMed Web of Science ®Google Scholar
• Xu K, Yin N, Peng M, Stamatiades EG, Shyu A, Li P, Zhang X, Do MH, Wang Z, Capistrano KJ. et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371(6527):405–410. doi:10.1126/science.abb2683.
   PubMed Web of Science ®Google Scholar
• Dabir DV, Hasson S, Setoguchi K, Johnson M, Wongkongkathep P, Douglas C, Zimmerman J, Damoiseaux R, Teitell M, Koehler C. et al. A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev Cell. 2013;25(1):81–92. doi:10.1016/j.devcel.2013.03.006.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi A H, Tanaseichuk O, Benner C, Chanda S K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1). doi:10.1038/s41467-019-09234-6.
   Web of Science ®Google Scholar
• Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics. 2006;7(1). doi:10.1186/1471-2105-7-191.
   Google Scholar
• Seo H, Chen J, González-Avalos E, Samaniego-Castruita D, Das A, Wang YH, López-Moyado IF, Georges RO, Zhang W, Onodera A. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8 + T cell exhaustion. Proc Natl Acad Sci USA. 2019;116(25):12410–12415. doi:10.1073/pnas.1905675116.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou J, Li X, Zhang X, Shi J, Wang X, Li H, Miao S, Chen H, He X. et al. tRNA-m(1)A modification promotes T cell expansion via efficient MYC protein synthesis. Nat Immunol. 2022;23(10):1433–1444. doi:10.1038/s41590-022-01301-3.
   PubMed Web of Science ®Google Scholar
• Ron-Harel N, Santos D, Ghergurovich J, Sage P, Reddy A, Lovitch S, Dephoure N, Satterstrom F, Sheffer M, Spinelli J. et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 2016;24(1):104–117. doi:10.1016/j.cmet.2016.06.007.
   PubMed Web of Science ®Google Scholar
• Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev. 2003;193(1):70–81. doi:10.1034/j.1600-065X.2003.00051.x.
   PubMed Web of Science ®Google Scholar
• Reina-Campos M, Scharping NE, Goldrath AW. CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21(11):718–738. doi:10.1038/s41577-021-00537-8.
   PubMed Web of Science ®Google Scholar
• Zehn D, Thimme R, Lugli E, de Almeida GP, Oxenius A. ‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses. Nat Immunol. 2022;23(6):836–847. doi:10.1038/s41590-022-01219-w.
   PubMed Web of Science ®Google Scholar
• Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281–295. doi:10.1016/j.immuni.2007.07.010.
   PubMed Web of Science ®Google Scholar
• Yao C, Sun H-W, Lacey NE, Ji Y, Moseman EA, Shih H-Y, Heuston EF, Kirby M, Anderson S, Cheng J. et al. Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection. Nat Immunol. 2019;20(7):890–901. doi:10.1038/s41590-019-0403-4.
   PubMed Web of Science ®Google Scholar
• Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, Ren X, Wang L, Wu X, Zhang J. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474. doi:10.1126/science.abe6474.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin Y-T, Togashi Y, Kamada T, Irie T, Okumura G, Kono H. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201–218.e9. doi:10.1016/j.ccell.2022.01.001.
   PubMed Web of Science ®Google Scholar
• Elia I, Rowe JH, Johnson S, Joshi S, Notarangelo G, Kurmi K, Weiss S, Freeman GJ, Sharpe AH, Haigis MC. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells. Cell Metab. 2022;34(8):1137–1150.e1136. doi:10.1016/j.cmet.2022.06.008.
   PubMed Web of Science ®Google Scholar
• Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M. et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–580. doi:10.1038/s41586-019-1678-1.
   PubMed Web of Science ®Google Scholar
• Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, Liao Y, Yan Y, Li Q, Zhou X. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer’s disease. Cell Metab. 2022;34(4):634–648.e636. doi:10.1016/j.cmet.2022.02.013.
   PubMed Web of Science ®Google Scholar
• Ji L, Lu B, Zamponi R, Charlat O, Aversa R, Yang Z, Sigoillot F, Zhu X, Hu T, Reece-Hoyes JS. et al. USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin. Nat Commun. 2019;10(1):4184. doi:10.1038/s41467-019-12143-3.
   PubMedGoogle Scholar
• Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV, Rittenhouse NL, DePeaux K, Whetstone RD. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645–651. doi:10.1038/s41586-020-03045-2.
   PubMed Web of Science ®Google Scholar
• Mendler AN, Hu B, Prinz PU, Kreutz M, Gottfried E, Noessner E. Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation. Intl J Cancer. 2012;131(3):633–640. doi:10.1002/ijc.26410.
   PubMed Web of Science ®Google Scholar
• Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci. 2019;44(2):153–166. doi:10.1016/j.tibs.2018.10.011.
   PubMed Web of Science ®Google Scholar
• Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE, Morris ME, Daws LC. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacol Rev. 2020;72(2):466–485. doi:10.1124/pr.119.018762.
   PubMed Web of Science ®Google Scholar
• Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V. et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550(7674):128–132. doi:10.1038/nature24028.
   PubMed Web of Science ®Google Scholar
• Chauhan D, Tian Z, Nicholson B, Kumar K, Zhou B, Carrasco R, McDermott J, Leach C, Fulcinniti M, Kodrasov M. et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell. 2012;22(3):345–358. doi:10.1016/j.ccr.2012.08.007.
   PubMed Web of Science ®Google Scholar
• Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19(12):775–790. doi:10.1038/s41571-022-00689-z.
   PubMed Web of Science ®Google Scholar
• Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, Lieb DJ, Chen JH, Frederick DT, Barzily-Rokni M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2018;175(4):998–1013.e1020. doi:10.1016/j.cell.2018.10.038.
   PubMed Web of Science ®Google Scholar
• Frebel H, Nindl V, Schuepbach RA, Braunschweiler T, Richter K, Vogel J, Wagner CA, Loffing-Cueni D, Kurrer M, Ludewig B. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med. 2012;209(13):2485–2499. doi:10.1084/jem.20121015.
   PubMed Web of Science ®Google Scholar
• Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, Yates KB, Lako A, Felt K, Naik GS. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20(3):326–336. doi:10.1038/s41590-019-0312-6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, Fang Y, Deng J, Gao Y, Liang X. et al. IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22(3):358–369. doi:10.1038/s41590-020-00850-9.
   PubMed Web of Science ®Google Scholar
• Mo F, Yu Z, Li P, Oh J, Spolski R, Zhao L, Glassman CR, Yamamoto TN, Chen Y, Golebiowski FM. et al. An engineered IL-2 partial agonist promotes CD8(+) T cell stemness. Nature. 2021;597(7877):544–548. doi:10.1038/s41586-021-03861-0.
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–337. doi:10.1038/nrc3038.
   PubMed Web of Science ®Google Scholar
• Kaymak I, Luda KM, Duimstra LR, Ma EH, Longo J, Dahabieh MS, Faubert B, Oswald BM, Watson MJ, Kitchen-Goosen SM. et al. Carbon source availability drives nutrient utilization in CD8+ T cells. Cell Metab. 2022;34(9):1298–1311.e6. doi:10.1016/j.cmet.2022.07.012.
   PubMed Web of Science ®Google Scholar
• Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, Wilhelm J, Li S, Song J, Li W. et al. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nat Commun. 2022;13(1):4981. doi:10.1038/s41467-022-32521-8.
   PubMed Web of Science ®Google Scholar
• Granieri L, Marocchi F, Melixetian M, Mohammadi N, Nicoli P, Cuomo A, Bonaldi T, Confalonieri S, Pisati F, Giardina G. et al. Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors. Cell Rep. 2022;40(12):111396. doi:10.1016/j.celrep.2022.111396.
   PubMed Web of Science ®Google Scholar
• Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, Sun Y, Hu Y, Wu B, Wu G. et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10(20):9332–9347. doi:10.7150/thno.47137.
   PubMed Web of Science ®Google Scholar
• Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, Rincon-Restrepo M, Franco F, Genolet R, Cheng W-C. et al. Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540–1551. doi:10.1038/s41590-020-0793-3.
   PubMed Web of Science ®Google Scholar
• Horn D, Zhou W, Trevisson E, Al-Ali H, Harris TK, Salviati L, Barrientos A. The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis. J Bio Chem. 2010;285(20):15088–15099. doi:10.1074/jbc.M110.104786.
   PubMed Web of Science ®Google Scholar